SCHEMBL3393907

SCHEMBL3393907

Cc1ccc(NC(O)c2c(-c3ccc(F)cc3)nc3ccc(C)cn23)nc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 4/20 0.45
MAPT P10636 3/20 0.45
GABRA1 P14867 3/20 0.45
GABRB2 P47870 3/20 0.45
POLB P06746 1/20 0.45
NR1H4 Q96RI1 1/20 0.45
GAA P10253 2/20 0.40
GRM5 P41594 1/20 0.40
RAB9A P51151 3/20 0.39
NPC1 O15118 2/20 0.39
KDM4E B2RXH2 3/20 0.39
PKM P14618 1/20 0.39
PKLR P30613 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.38
TGFBR1 P36897 2/20 0.38
ALDH1A1 P00352 2/20 0.37
HPGD P15428 2/20 0.37
LMNA P02545 1/20 0.36
ALB P02768 1/20 0.36
CYP3A4 P08684 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3360536 0.89 TP53 (0.40) TP53MAPTGABRA1GABRB2POLB
SCHEMBL3363076 0.89 MAPT (0.48) TP53MAPTGABRA1GABRB2POLB
SCHEMBL3434736 0.85 NR1H4 (0.49) TP53NR1H4GAARAB9ANPC1
SCHEMBL3395127 0.83 AHR (0.37) TP53MAPTGABRA1GABRB2POLB
SCHEMBL14632083 0.81 GABRD (0.38) TP53MAPTGABRA1GABRB2GAA
SCHEMBL3393270 0.80 NR1H4 (0.51) MAPTNR1H4GAAKDM4EALDH1A1
SCHEMBL3394856 0.79 GAA (0.39) TP53MAPTPOLBNR1H4GAA
SCHEMBL3396264 0.78 CRHR1 (0.38) TP53MAPTPOLBNR1H4GAA
SCHEMBL3391218 0.76 MAPT (0.45) TP53MAPTGABRB2GAAKDM4E
SCHEMBL3397222 0.74 MAPK14 (0.34) TP53MAPTPOLBKDM4ETGFBR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS BIOVITRUM AB (PUBL) (SE) 2015-08-27 US disclosed
US-20140206662-A1 Imidazopyridine Compounds PROXIMAGEN LTD. (GB) 2014-07-24 US disclosed
EP-2376490-B1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD (GB) 2013-01-23 EP disclosed
WO-2010064020-A1 IMIDAZOPYRIDINE COMPOUNDS PROXIMAGEN LTD. (GB) 2010-06-10 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150239905-A1 IMIDAZOPYRIDINE COMPOUNDS SSB, MIF, IDO1 TP53 2306/4885MAPT 3076/4885GABRA1 1605/4885
US-20140206662-A1 Imidazopyridine Compounds SSB, NFKBIA, TPMT TP53 1815/4885MAPT 2195/4885GABRA1 1324/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.